MedPath

Alvogen, Inc.

Alvogen, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2009-01-01
Employees
1K
Market Cap
-
Website
http://www.alvogen.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

FDA:6

Drug Approvals

levothyroxine sodium

Approval Date
Jan 31, 2024
FDA

Oxycodone hydrochloride

Approval Date
Dec 31, 2023
FDA

teriparatide

Approval Date
Nov 20, 2023
FDA

Pyridostigmine Bromide

Approval Date
Nov 14, 2023
FDA

LENALIDOMIDE

Approval Date
Mar 6, 2023
FDA

Rasagiline

Approval Date
Feb 1, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.